The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma

This publication has 24 references indexed in Scilit:

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
  Archives of Pathology & Laboratory Medicine, 2007
• The Incidence and Anatomic Site Specificity of Chromosomal Translocations in Primary Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (MALT Lymphoma) in North America
  The American Journal of Surgical Pathology, 2006
• Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2
  Leukemia, 2006
• Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization
  Cancer Genetics and Cytogenetics, 2005
• A narrow deletion of 7q is common to HCL, and SMZL, but not CLL
  European Journal of Haematology, 2004
• Splenic Marginal Zone Lymphomas Presenting with Splenomegaly and Typical Immunophenotype Are Characterized by Allelic Loss in 7q31–32
  Laboratory Investigation, 2003
• Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes
  Genes, Chromosomes and Cancer, 2002
• Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics
  The American Journal of Pathology, 2001
• Deregulated PAX-5 Transcription From a TranslocatedIgH Promoter in Marginal Zone Lymphoma
  Blood, 1998
• Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
  Leukemia, 1997